Quantifying biogenic bias in screening libraries.

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Computational Chemistry

Background:

• High-throughput screening (HTS) is crucial for identifying biologically active compounds.
• The vast chemical space of drug-like molecules (estimated >10^60) makes exhaustive screening impossible.
• Current screening libraries, despite their size (approx. 10^6), yield occasional successes, implying inherent biases.

Purpose of the Study:

• To develop and apply a quantitative method for assessing bias in screening libraries.
• To identify the types of molecules that are over-represented or under-represented in current libraries.
• To provide insights for optimizing screening library design for more effective lead discovery.

Main Methods:

• Development of a computational approach to quantify the bias towards biogenic molecules in screening libraries.
• Analysis of existing screening libraries to identify patterns of molecular selection.
• Comparison of library composition against the broader chemical space.

Main Results:

• Quantification of a significant bias in current screening libraries favoring molecules of biogenic origin.
• Identification of specific chemical classes that are under-represented in typical screening libraries.
• Demonstration that library bias impacts the potential for novel lead discovery.

Conclusions:

• Current lead discovery screening libraries exhibit a notable bias towards biogenic molecules.
• This bias limits the exploration of diverse chemical matter, potentially hindering the discovery of novel drug leads.
• Optimization strategies focusing on reducing bias and expanding chemical diversity are essential for improving drug discovery success rates.